Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?

Key Takeaways DGX posted strong Q1 growth across brain health, oncology and women's health diagnostics. Strategic deals like LifeLabs and PathAI Diagnostics strengthen DGX's core and adjacent markets. DGX targets 3% annual cost savings with automation, Project Nova and GenAI partnerships.Quest Diagnostics Inc. (DGX) is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. The company’s growth strategy includes pursuing value-creating, strate ...